AMEX · Biotechnology

Armata Pharmaceuticals, Inc. (ARMP) Stock

$3.63 -5.96% AMEX: ARMP Healthcare

Valuation

MetricValue
Price$3.63
Market Cap$133.26M
P/E Ratio-0.72
P/B Ratio-0.61
P/S Ratio42.40
EPS (TTM)$0.00
52-Week High$16.34
52-Week Low$3.09
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE89.70%
ROA-213.65%
ROCE25.40%
Gross Margin-620.00%
Operating Margin-620.00%
Net Margin-95.54%
Debt/Equity-1.36
Current Ratio1.22

Annual Financials (USD)

Metric20212022202320242025
Revenue$4.0M$6.0M$5.0M$5.0M$5.0M
Operating Profit$-24.0M$-37.0M$-41.0M$-42.0M$-31.0M
Net Profit$-23.0M$-37.0M$-69.0M$-19.0M$-174.0M
EPS$-0.96$-1.08$-1.91$-0.52$-4.80
Op Margin-532.5%-670.8%-902.9%-820.2%-636.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$70.0M$108.0M$98.0M$86.0M$77.0M
Total Liabilities$44.0M$72.0M$130.0M$134.0M$295.0M
Cash$10.0M$15.0M$14.0M$9.0M$9.0M
Borrowings$38.0M$49.0M$120.0M$127.0M$288.0M

Latest News

Armata Pharma Reaches FDA Agreement on Pediatric Study Plan for AP-SA02 MT Newswires · Jul 13, 2026 Armata Pharmaceuticals Receives Agreement from FDA on Initial Pediatric Study Plan for AP-SA02 for the Treatment of Complicated Staphylococcus aureus Bacteremia PR Newswire · Jul 13, 2026 Sector Update: Healthcare Stocks Mixed Pre-Bell Tuesday MT Newswires · Jun 23, 2026 Armata Pharmaceuticals Receives Additional $2.5 Million in Funding From US Department of Defense MT Newswires · Jun 23, 2026 Armata Pharmaceuticals Receives $2.5 Million of Additional Non-Dilutive Award Funding from the U.S. Department of Defense to Support AP-SA02 PR Newswire · Jun 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-24.0M$-32.0M$-47.0M$-38.0M$-26.0M
Investing Cash Flow$-3.0M$-4.0M$-16.0M$-4.0M$-1.0M
Financing Cash Flow$-1.0M$0$0$0$0
Net Cash Flow$1.0M$5.0M$-2.0M$-4.0M$-1.0M
Free Cash Flow$-25.0M$-35.0M$-56.0M$-39.0M$-26.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA-2.54
FCF Yield-18.44%
Quick Ratio0.11
Interest Coverage-1.90
Return 1Y71.18%
Return 3Y216.13%
Return 5Y3.16%

Ownership

Insiders Held68.55%
Institutions Held10.46%
Institutions Float Held33.25%
Institutional HolderSharesReport Date
Madison Asset Management, LLC2,107,6752026-03-31
Vanguard Capital Management LLC366,0282026-03-31
Millennium Management Llc257,9922026-03-31
683 Capital Management LLC137,0002026-03-31
Geode Capital Management, LLC114,5552026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc. is led by CEO Deborah L. Birx, employs 60 people, headquartered in US, publicly traded since 1994.

Armata Pharmaceuticals, Inc. (ARMP) stock trades at $3.63 with a market capitalization of $133.26M. The stock is valued at a price-to-earnings (P/E) ratio of -0.72, price-to-book of -0.61, price-to-sales of 42.40. Over the past 52 weeks the stock has ranged between $3.09 and $16.34, and currently trades 77.8% below its 52-week high.

On profitability, Armata Pharmaceuticals, Inc. generates a return on equity (ROE) of 89.70% — well above the market average, a sign of a high-quality business, return on capital employed of 25.40%, an operating margin of -620.00%, a net profit margin of -95.54%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides